Liquid Biopsy Assessment of Molecular Residual Disease in Localized Colorectal Cancer: Is It Ready for Prime Time?

Juan Ruiz-Bañobre^{1

2

3

4}, Ajay Goel^{5

6}

Affiliations

¹ Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), A Coruña, Spain.
² Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), A Coruña, Spain.
³ Genomes and Disease, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), A Coruña, Spain.
⁴ Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
⁵ Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Biomedical Research Center, Monrovia, California.
⁶ City of Hope Comprehensive Cancer Center, Duarte, California.

Editorial

Juan Ruiz-Bañobre et al. JAMA Oncol. 2023.

. 2023 Jun 1;9(6):763-764.

doi: 10.1001/jamaoncol.2023.0329.

Juan Ruiz-Bañobre^{1

2

3

4}, Ajay Goel^{5

6}

¹ Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), A Coruña, Spain.
² Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), A Coruña, Spain.
³ Genomes and Disease, Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), A Coruña, Spain.
⁴ Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
⁵ Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Biomedical Research Center, Monrovia, California.
⁶ City of Hope Comprehensive Cancer Center, Duarte, California.

No abstract available

Comment on

Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation.
Mo S, Ye L, Wang D, Han L, Zhou S, Wang H, Dai W, Wang Y, Luo W, Wang R, Xu Y, Cai S, Liu R, Wang Z, Cai G. Mo S, et al. JAMA Oncol. 2023 Jun 1;9(6):770-778. doi: 10.1001/jamaoncol.2023.0425. JAMA Oncol. 2023. PMID: 37079312 Free PMC article.